GlaxoSmithKline v. Classen Immunotherapies, Inc.Petition for certiorari denied on January 14, 2013
|Docket No.||Op. Below||Argument||Opinion||Vote||Author||Term|
|11-1078||Fed. Cir.||N/A||N/A||N/A||N/A||OT 2012|
Issue: Whether the Federal Circuit’s interpretation of 35 U.S.C. § 271(e)(1)’s safe harbor from patent infringement liability for drugs – an interpretation which arbitrarily restricts the safe harbor to pre-marketing approval of generic counterparts – is faithful to statutory text that contains no such limitation and decisions of this Court rejecting similar efforts to impose extra-textual limitations on the statute.
Plain English Summary:
- Petition of the day (Matthew Bush)